Xconomy |
Veritas Buys Curoverse to Bring AI Analysis of Genes to the Masses
Xconomy Veritas, a Boston startup, has already made genetic analysis more affordable by bringing the cost of whole genome sequencing below $1,000. But to reach the future that Martinez envisions, the company needs the capability to go beyond the hundreds of … Veritas Genetics Acquires Curoverse to Deploy Large-Scale Artificial Intelligence and Machine Learning in GenomicsPR Newswire (press release) all 3 news articles » |
Source: Genome Sequencing